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Abstract
Chikungunya virus (CHIKV) is a recently re-emerged public health problem in many countries bordering the Indian Ocean
and elsewhere. Chikungunya fever is a relatively self limiting febrile disease, but the consequences of chikungunya fever can
include a long lasting, debilitating arthralgia, and occasional neurological involvement has been reported. Macrophages
have been implicated as an important cell target of CHIKV with regards to both their role as an immune mediator, as well
evidence pointing to long term viral persistence in these cells. Microglial cells are the resident brain macrophages, and so
this study sought to define the proteomic changes in a human microglial cell line (CHME-5) in response to CHIKV infection.
GeLC-MS/MS analysis of CHIKV infected and mock infected cells identified some 1455 individual proteins, of which 90
proteins, belonging to diverse cellular pathways, were significantly down regulated at a significance level of p,0.01.
Analysis of the protein profile in response to infection did not support a global inhibition of either normal or IRES-mediated
translation, but was consistent with the targeting of specific cellular pathways including those regulating innate antiviral
mechanisms.
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Introduction
Chikungunya virus (CHIKV) is the causative agent of the
mosquito transmitted disease chikungunya fever and infection of
humans with CHIKV results an illness traditionally characterized
by high fever, rash, arthritis and an erratic relapsing and
incapacitating arthralgia [1,2]. The disease was first formally
described after an outbreak in 1952 in Tanzania [3] and the virus
was first isolated from the same outbreak [4].
CHIKV is an enveloped icosahedral, positive single-stranded-
RNA virus, belonging to the genus Alphavirus in the family
Togaviridae, and the approximately 11.8 kb genetic material which
contains a 59-methylguanylate cap and a 39-polyadenylate tail [5]
codes for 4 non-structural proteins (nsP1 to nsP4), three structural
proteins (capsid, E1 and E2) and two small peptides (E3 and 6K) in
two open reading frames [5,6]. After entry to a host cell by
endocytosis [7] and uncoating, the genomic RNA is translated
directly into the four non-structural proteins which are encoded by
the 59-two thirds of the genome. These proteins collectively form
the replicative enzyme complex which mediates the replication of
the viral genome and transcription of a 26S subgenomic RNA
which encodes for the structural proteins [6]. The four
nonstructural proteins possess methyltransferase and guanyltrans-
ferase activity (nsP1), protease, helicase, NTPase and 59 triphos-
phatase activity (nsP2), RNA dependent polymerase and adenyl-
transferase activity (nsP4) while nsP3 is predominantly responsible
for synthesis of the minus strand RNA replicative intermediate [6].
There are three lineages of CHIKV the so called West African,
East Central and South African (ECSA) and Asian lineages, and as
the names imply the first two are predominantly associated with
transmission in Africa, while the Asian lineage, which is believed to
have diverged from the ECSA lineage between 50 and 300 years
ago circulates in Asia [8,9]. CHIKV is transmitted by the bite of
infected mosquitoes of the Aedes genus, and in Asia the virus is
maintained in an urban transmission cycle between humans and
the anthropophilic Aedes aegypti, while in African the virus is
believed to be maintained in a primarily sylvatic cycle between
non-human primates and forest dwelling Aedes mosquito species
[1,10].
While CHIKV has been present at low levels in Africa, India
and Southeast Asia over the last 50 years [11], it re-emerged into
prominence as a major public health concern after the massive
outbreak in La Reunion in 2007 and the subsequent outbreaks in
India, Sri Lanka, Singapore, Malaysia, and Thailand over the
following years [9,12,13,14]. Of particular concern was the
adaptation of the virus to Aedes albopictus hosts [15] which drove
much of the outbreak, as well as led to autochthonous outbreaks in
Europe [16,17] and the possibility of significantly greater spread
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Chikungunya is classified as an ‘‘Old world’’ alphavirus together
with Sindbis virus and Semliki Forest virus and these viruses are
predominantly arthralgic in presentation, as opposed to the ‘‘New
world’’ alphaviruses (such as Venezuelan equine encephalitis virus
and Eastern equine encephalitis virus) that are predominantly
encephalitic in presentation [6]. However, over the last few
decades, there have been increasing number of reports of severe
chikungunya with outbreaks in India in the early 1960 s being
associated with neurological and hematological complications
[19,20] while recent outbreaks from 2005 onward have been
associated with severe encephalitis and meningioencephalitis, as
well as an increasing number of fatalities, particularly in the elderly
or those with other existing conditions [12,13,21,22,23].
The tissue tropism of CHIKV in humans is not completely
defined, but epithelial, endothelial and fibroblast cells [2] as well as
monocytes [24] and in particular monocyte derived macrophages
[25] have all been proposed to be involved in the disease
pathology, while in the brain both neurons and glial cells have
been implicated [22], a finding consistent with the reported
neurological involvement [12,22].
Microglial cells are specialized brain resident macrophages of
the central nervous system that are hematopoietic in origin and act
as the primary cellular response to invading pathogens or injury
[26]. Microglial cells are resident in the parenchyma, and animal
model studies suggest that where the CNS is involved in CHIKV
infection, it occurs primarily at the level of the meningeal and
ependymal layers rather than occurring at the parenchyma [27],
and supporting this, where studies have examined microglial cells
directly no antigen positive cells were detected [25]. However,
activation of microglial cells has been reported in CHIKV
infection [28] and while human studies have shown that neonatal
encephalopathy lesions were associated primarily with the white
matter [27], microglial cells are present in the white matter of
normal human brain, although less frequently than in the grey
matter [29].
While mouse studies have suggested that microglial cells are
refractory to infection [21], our recent study has shown that the
transformed microglial cell line CHME-5 is productively highly
permissive to CHIKV infection, with the resultant induction of
apoptosis [30]. The induction of apoptosis is a common result of
infection of mammalian cells with CHIKV [2,31]. Prior to this
however, it is well established that both old and new world
alphaviruses induce transcriptional and translational shut off,
possibly as a way to avoid antiviral responses during replication
[32,33]. Interestingly, new world alphaviruses use the nsP2 protein
to down regulate RNA polymerase I and II transcription while the
Old world alphaviruses achieve the same result through the
expression of the capsid protein [32]. CHIKV has been shown to
induce translational shut off, although the mechanism remains to
be explained [34].
As noted earlier, microglial cells are a specialized lineage
macrophage [26] and macrophages have been implicated as a long
lasting reservoir for CHIKV in animal model studies [25]. In
parallel with this we have recently proposed [35] that microglial
cells are a long lasting reservoir for the Japanese encephalitis virus
(JEV). While the involvement of microglial cells is more
pronounced in JEV infections, our study showing that transformed
microglial cells are productively infected [30], coupled with the
fact that, while rare, neurological involvement in CHIKV
infection particularly in neonates has severe consequences
[12,19,20,22] prompted us to more fully examine the cellular
consequences of CHIKV infection of microglial cells, using
transformed cells as a model system.
Materials and Methods
Ethics statement
CHIKV E1: 226 V was isolated as part of a study approved by
the Mahidol University Institutional Review Board (COA.
NO. MU-IRB 2010/251.3018) and by the Ethics Review Board
of Pang Nga Hospital, Thailand. Written informed consent was
obtained.
Cells and virus
The human embryonic fetal microglial cell line CHME-5 [36]
was kindly provided by Professor Pierre Talbot, Laboratory of
Neuroimmunovirology, INRS-Institute, Armand-Frappier, Cana-
da and both CHME-5 and Vero (African green monkey kidney;
ATCC Cat No. CCL-81) cells were grown and maintained in
Dulbecco’s modified eagle’s medium (DMEM; Gibco, Invitrogen,
Carlsbad, CA) supplemented with 10% or 5% heat-inactivated
fetal bovine serum (FBS; Gibco, Invitrogen) respectively and
100 units/ml of penicillin/streptomycin (PAA Laboratories
GmbH, Pasching, Austria) at 37uC with 5% CO2. CHIKV
(ECSA genotype, Thai isolate E1: 226 V) was propagated in Vero
cells and infectious virus titer was determined by standard plaque
assay on Vero cells.
Virus infection
A day prior to infection, CHME-5 cells were seeded into cell
culture dishes at a density that allowed confluence to be reached
within 24 hours. At the time of infection the medium was
aspirated immediately before inoculating the cells with CHIKV at
the required multiplicity of infection (MOI) diluted in ice-cold
serum free medium. Cells were then incubated at 37uC with 5%
CO2 for 2 hours, with gentle rocking every 20 minutes for 2 hours
after which the medium was removed and pre-warmed DMEM
supplemented with 10% FBS was added to each dish. The cells
were then incubated at 37uC with 5% CO2 until required.
Flow cytometry
For analysis of apoptosis, mock and CHIKV infected cells were
collected at day 2 p.i. and washed with ice-cold PBS and were
resuspended in binding buffer (BD, Franklin Lakes, NJ), followed
by double staining with the addition of 50 mg/ml FITC-
conjugated Annexin V and 20 mg/ml propidium iodide. After
15 min, the cells were analyzed by flow cytometry on a
FACSCalibur cytometer (BD Biosciences, San Jose, CA) using
CELLQuestTM software.
To quantify the infected cells, mock and CHIKV infected cells
were harvested and blocked with 10% normal goat serum for
30 min on ice. Cells were washed with 1% BSA followed by
fixation in 4% paraformaldehyde at room temperature for 20 min
and subsequently permeabilized with 0.2% Triton X-100 in 1%
BSA for 10 min at room temperature. Cells were then incubated
with a mouse anti-alphavirus monoclonal antibody (Santa Cruz
Biotechnology Inc., Santa Cruz, CA) at a dilution of 1:200 at 4uC
overnight. After three washes with 1% BSA, cells were incubated
with a FITC conjugated goat anti-mouse IgG polyclonal antibody
(KPL Inc., Gaithersburg, MD) at dilution of 1:20 at room
temperature for 1 h. Cells were washed three times with 1% BSA
and resuspended in 16PBS and analyzed by flow cytometry (BD
Biosciences) using the CELLQuest
TM software (BD Biosciences).
To detect both CHIKV infection and the presence of active
caspase 3, the protocol above was followed exactly except that
CHIKV Infection Proteomic Analysis
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washed twice with 1% BSA and then washed once with BD Perm/
Wash buffer (BD Biosciences, San Diego, CA) and cells were
subsequently incubated with a phycoerythrin conjugated anti-
active caspase 3 antibody according to the manufacturers protocol
(BD Biosciences) prior to flow cytometry.
Protein extraction for 2D-PAGE
Mock and CHIKV infected cells were scraped into 2 ml of
serum free medium and centrifuged at 1,800 rpm for 5 minutes.
Cells were then resuspended in 1 ml of 16PBS and centrifuged
again at 1,800 rpm for 5 minutes and cell pellets were resus-
pended in 500 ml ice-cold lysis buffer (7 M urea, 2 M thiourea ,4%
w/v CHAPS, and 100 mM dithiothreitol (DTT) containing 1%
protease inhibitor cocktail (Bio Basic Inc., Markham, Ontario,
Canada). After cell lysis, samples were sonicated at 4uC for
5 minutes 4 times and centrifuged at 19,4006g for 25 minutes at
4uC. The supernatants were then transferred in to new tubes and
kept at 280uC until required. Protein concentrations were
determined using the Bradford protein assay.
2D-PAGE
A total of 250 mg of protein was added to the rehydration buffer
(7 M urea, 2 M thiourea, 4% w/v CHAPS, 97 mM dithiothreitol
(DTT), 2%v/v IPG buffer (pH3-10, non-linear), 1% bromophenol
blue and protease inhibitor cocktail to a final volume of 130.5 ml.
The mixture was then centrifuged at 12,000 rpm for 5 minutes
and loaded to 7 cm Ettan IPGphor strip holder. The 7 cm, non-
linear pH 3–10, Immobilized pH gradient (IPG, GE Healthcare,
Buckinghamshire, UK) strips were allowed to rehydrate at 20uC
for 16 hours applying 50 mA constant current per IPG strip using
Ettan IPGphor system (GE Healthcare). After isoelectric focusing
(IEF; step 1, 300 v, 1200 vh; step 2, 1000 v, 300 vh, step 3,
3000 v, 4000 vh; step 4, 5000 v, 4500 vh; step 5, 5000 v, 3000 vh
and step 6 100 v, 10.00 hr), the IPG strips were reduced in
50 mM Tris–HCl (pH 8.8), 6 M urea, 30% v/v glycerol, 2% SDS
w/v, 50 mg DTT and 1% bromophenol blue for 20 min and then
alkylated in the same buffer containing 170 mM iodoacetamide
(IAA) for 45 minutes. The equilibrated gel strips were then placed
onto 8 mm68 mm 12.5% sodium dodecyl sulphate polyacryl-
amide gels (SDS-PAGE) and run at 20 mA/gel constant current
for the second dimension separation. After separation, the gels
were stained with colloidal Coomassie Brilliant Blue G250 in 40%
methanol for 48 hrs and destained with milliQ water for 48 hours,
scanned and analyzed with ImageMaster
TM 2D Platnium software
version 4.9 (GE Healthcare). Manual editing and removal of
artifacts was undertaken after automatic spot detection at default
parameters. Samples were analyzed in 6 biological replications for
each condition.
Protein extraction for GeLC-MS/MS
Triplicates of CHME-5 cells grown in 60 mm cell culture dish
and either mock infected or infected with CHIKV at MOI of 2.5
were collected at 2 d.p.i. by scraping and cells were pelleted by
centrifugation at 5006 g. After washing with 16 PBS, the cell
pellet was resuspended in MilliQ water and 2 volume of ice-cold
100% acetone was added and samples were stored at 230uC until
required. The frozen cells were subsequently thawed and
centrifuged at 9,2006 g for 10 min. The protein pellets were
dried in a fume hood for 30 min and samples were resuspended in
0.5% SDS in water. Protein concentration was measured using the
Lowry protein assay and 50 mg of protein/lane from each sample
was loaded and separated on a 12.5% SDS-PAGE gel. The gel
was then stained with colloidal Coomassie blue G and each lane
cut into 16161m m
3 sized gel plugs.
In-gel digestion
The gel plugs were placed in wells of a 96 well plate and washed
with 200 ml/well of sterile milliQ water by shaking for 5 min at
room temperature followed by destaining with 25 mM NH4HCO3
in 50% methanol until the gel plugs were clear. Destaining
solution was removed by washing three times with sterile milliQ
water and samples were dehydrated by the addition of 200 ml/well
of 100% acetonitrile (ACN) and shaking for 5 min at room
temperature and samples were allowed to dry at room temper-
ature for 10 min. The proteins were then reduced by the addition
of 20 ml/well of 10 mM dithiothreitol (DTT) in 10 mM
ammonium bicarbonate (NH4HCO3) and incubation at 56uC
for 1 hr and then alkylated by the addition of 20 ml/well of
100 mM IAA in 10 mM NH4HCO3 and further incubation at
room temperature in the dark for 1 h followed by washing twice
with 100% ACN. The proteins were digested by the addition of
20 ng/well of trypsin in 10 mM NH4HCO3 and incubation at
room temperature for 20 min followed by incubation at 37uC for
3 hrs. The solutions were then transferred to a new low binding 96
well plate. The remaining peptides in the original plate were then
extracted twice by the addition of 30 ml/well of 50% ACN in 0.1%
formic acid (FA) followed by shaking at room temperature for
10 min and the solutions added to the original digestion solution.
The final extracted solution was then incubated at 40uC until dry
and samples were kept at 280uC until analysis by LC-MS/MS.
LC-MS/MS
The dried samples were first dissolved in 10–12 ml/well of 0.1%
FA in LC-MS grade water and transferred to the vial for injection.
Nanoscale LC separation of tryptic peptides was performed with
an Ultimate 3000 LC System (Dionex, USA) coupled to ESI-Ion
Trap MS (HCT Ultra PTM Discovery System (Bruker, Germany))
with electrospray at a flow rate of 300 nl/min to a nanocolumn
(Onyx monolithic HDC18, 0.2 mm i.d.6150 mm). Mobile phase
A was 0.1% formic acid in water, and mobile phase B was 80%
acetonitrile with 0.1% formic acid. A multistep gradient was used
to elute peptides: a linear increase from 10%–70% B for 13 min,
90% B at 13–15 min followed by a decrease to 10%B at 15–
20 min. Peptide fragment mass spectra were acquired in data-
dependent AutoMS mode with a scan range of 30021500 m/z,3
averages, and up to 5 precursor ions selected from the MS scan
5023000 m/z.
Protein quantitation and identification
For protein quantitation, DeCyder MS Differential Analysis
software (DeCyderMS, GE Healthcare [37,38]) was used.
Acquired LC-MS raw data were converted and the PepDetect
module was used for automated peptide detection, charge state
assignments, and quantitation based on the peptide ions signal
intensities in MS mode. The analyzed MS/MS data from
DeCyderMS were submitted for a database search using the
Mascot software (Matrix Science, London, UK, [39]). The data
was searched against the NCBI database for protein identification.
Database interrogation was; taxonomy (Human); enzyme (trypsin);
variable modifications (carbamidomethyl, oxidation of methionine
residues); mass values (monoisotopic); protein mass (unrestricted);
peptide mass tolerance (1.2 Da); fragment mass tolerance
(60.6 Da), peptide charge state (1+,2 + and 3+) and max missed
cleavages (3). Proteins considered as identified proteins had at least
one peptide with an individual mascot score corresponding to
p,0.05.
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Mock and CHIKV infected cells were collected as described
before and resuspended in 50 ml/10
6 cells of RIPA lysis buffer (1%
Nonidate P-40, 0.5% sodium deoxycholate and 0.1% SDS in 16
PBS and PIC added) followed by four rounds of sonication, each
for round for 4 min. The cell lysates were then centrifuged at
10,0006g for 15 min and the supernatant kept as a protein stock.
30 mg of total proteins were separated on 10% SDS-PAGE gels
and transferred onto 0.2 mm nitrocellulose membranes (Whatman
GmbH, Germany) using a constant 30 volts overnight. The
membranes were then blocked with 5% skim milk for an hour and
probed with an appropriate primary antibody in 5% skim milk for
another hour. After incubation with an appropriate secondary
antibody conjugated with horseradish peroxidase (HRP) for an
hour, the signals were developed using the ECL Prime western
blot detection reagent (RPN 2232, GE Healthcare) and detected
using autoradiography film. Antibodies used included a 1:400
dilution of a rabbit anti-JAK 2 polyclonal antibody (sc-278; Santa
Cruz Biotechnology Inc.), a 1:6,000 dilution of a rabbit anti-
Hsp90 polyclonal antibody (sc-7947; Santa Cruz Biotechnology
Inc.), a 1:4,000 dilution of a rabbit anti-Hsp70 polyclonal antibody
(sc-1060; Santa Cruz Biotechnology Inc.), a 1:5,000 dilution of a
rabbit anti-nucleolin polyclonal antibody (sc-13057; Santa Cruz
Biotechnology Inc.), a 1:3,000 dilution of a rabbit anti-heteroge-
neous nuclear ribonucleoprotein polyclonal antibody (ab65049;
Abcam, Cambridge, MA), a 1:10,000 dilution of a rabbit anti-
elongation factor 2 polyclonal antibody (ab33523; Abcam) all
followed by a 1:4,000 dilution of a goat horseradish peroxidase
(HRP) conjugated anti-rabbit IgG polyclonal antibody (31460;
Pierce, Rockford, IL) as well as a 1:5,000 dilution of a goat anti-
actin polyclonal antibody (sc-1616; Santa Cruz Biotechnology
Inc.) followed by a 1:8,000 dilution of a rabbit HRP conjugated
anti-goat IgG polyclonal antibody (31402; Pierce), as well as a
1:1000 dilution of a mouse anti-alphavirus monoclonal antibody
(Santa Cruz Biotechnology Inc., Santa Cruz, CA) followed by a
1:5,000 dilution of a rabbit HRP conjugated anti-mouse IgG
polyclonal antibody (A9044; Sigma, Sigma-Aldrich, St Louis,
MO).
Semi-quantitative RT-PCR
Total RNA was extracted from infected and mock control
CHME-5 cells by using TRI reagentH (Molecular Research
Center, Inc., Cincinnati, OH). cDNAs were synthesized from
1.0 mg of total RNA using oligo (dT) primer (Bio Basic, Inc.) and
ImpromII
TM reverse transcriptase (Promega, Madison, WI).
Specific primers for each gene were used to amplify the
Figure 1. Analysis of CHIKV infected CHME-5 cells. CHME-5 cells either mock infected or infected with CHIKV at MOI 0.1 were collected at day 2
p.i. (A, B, D) or on days 1 to 3 p.i. (C) and subsequently (A) stained with an anti-alphavirus antibody and the percentage of infected cells analyzed by
flow cytometry or (B) stained with Annexin V-FITC and PI and the percentage of apoptotic cells analyzed by flow cytometery or (C, D) used for total
protein extraction and (C) analyzed by western blotting with an anti-alphavirus monoclonal antibody and an anti-actin polyclonal antibody or (D) the
differential proteome determined by 2D-PAGE. Representative gels from 6 biological replicates are shown. (A and B) Bar graphs represent the means
6 SD of 6 replications.
doi:10.1371/journal.pone.0034800.g001
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and expected product sizes are given in Supplementary Table S1.
The PCR products were then separated on 2% agarose gel and
products visualized by staining with ethidium bromide.
Results
2D-PAGE analysis of CHIKV infected CHME-5 cells
To confirm the susceptibility of CHME-5 cells to CHIKV, cells
were infected at MOI 0.1 and on day 2 p.i. fixed, permeabilized
and stained with a monoclonal anti-alphavirus antibody followed
by an appropriate FITC-conjugated secondary antibody before
being analyzed in a flow cytometer. Results (Figure 1A) showed
that slightly more than 80% of cells were infected at this time
point. Under this protocol, less than 20% of cells were undergoing
apoptosis as assessed by FITC conjugated Annexin V/propidium
iodide staining (Figure 1B). These results are compatible with our
previous study undertaken at MOI 1 [30]. While the percentage of
apoptotic cells in this study is markedly lower than that reported in
a previous study on CHIKV infected HeLa cells [2], that study
was undertaken at MOI 10. We further established that infection
was coupled with the production of viral proteins by infecting
CHME-5 cells with CHIKV at MOI 0.1 and analyzing the
expression of CHIKV proteins via western blot analysis using an
Figure 2. Infection and apoptosis in CHIKV infected CHME-5 cells. (A and B) CHME-5 cells either mock infected or infected with CHIKV at MOI
2.5 or 5 were collected at day 2 p.i. and (A) cells were stained with an anti-alphavirus antibody and the percentage of infected cells was determined
by flow cytometry or (B) cells were stained with Annexin V-FITC and PI and the percentage of induced apoptosis determined by flow cytometery. Bar
graphs represent the means 6 SD of 3 replications per group. (C and D) CHME-5 cells either mock infected or infected with CHIKV at MOI 2.5 or 5
were collected on days 2 and 4 p.i. and analyzed by flow cytometry after double staining with antibodies directed against active caspase 3 and
alphavirus. Experiment was undertaken in three independent replicates. Representative flow cytometry dot plot is shown in (C) and data is shown
graphically in (D). Bar graphs represent the means 6 SD of 3 replications per group.
doi:10.1371/journal.pone.0034800.g002
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infected cells (Figure 1C) which showed robust CHIKV protein
expression on day 2 p.i. which is consistent with our previous data
showing CHIKV protein expression in infected CHME-5 cells by
immunocytochemistry [30].
To provide an initial analysis of the proteomic changes in
CHME-5 cells in response to CHIKV infection, cells were infected
or mock infected with CHIKV at MOI of 0.1 and on day 2 p.i.
cells were lysed and the harvested proteins subjected to 2D analysis
in parallel with mock infected cells. Experiment was undertaken as
six independent replicates. Results (Figure 1D) showed that a total
of 59 protein spots were differentially expressed (at p,0.05) in
response to CHIKV infection, with 58 of these spots being down
regulated (with 13 spots being found only in the mock infected
samples) while 1 spot was up-regulated in the infected cells. Given
the apparent large number of proteins differentially regulated in
response to CHIKV analysis, further analysis was conducted by
GeLC-MS/MS.
GeLC-MS/MS Analysis
Before undertaking the GeLC-MS/MS analysis, the level of
infection was re-optimized to ensure nearly all cells were infected.
Cells were infected at MOI 2.5 and 5 as previously, and cells were
analyzed for the levels of infection and induction of apoptosis by
flow cytometry as previously. Results showed that both MOI 2.5
and 5 gave nearly 100% infection (Figure 2A), albeit with a slight
increase in the number of cells undergoing apoptosis (Figure 2B).
To confirm that the cells undergoing apoptosis were CHIKV
infected cells, cells were infected at MOI 2.5 and 5 as previously,
and cells were analyzed on days 2 and 4 p.i. by double staining
with antibodies directed against active caspase 3 and against
alphaviruses. Results (Figure 2C, D) showed that the percentage of
active caspase 3 positive cells on day 2 was in close agreement with
the percentage of Annexin V/propidium iodide positive cells as
seen in the earlier analysis (Figure 2B) for both MOI 2.5 and 5 and
moreover that the active caspase 3 positive cells correlated with
alphavirus positive cells over the period of the experiment
(Figure 2C).
CHME-5 cells were therefore mock infected or infected with
CHIKV at MOI 2.5 and on day 2 p.i. proteins were harvested and
subjected to GeLC-MS/MS analysis. Experiment was undertaken
as three independent replicates.
GeLC-MS/MS analysis revealed a total of 1455 differentially
expressed proteins, of which 90 proteins were differentially
expressed at a significance level of p,0.01 (Figure 3). Two-way
hierarchical clustering analysis (Figure 4) of these differentially
expressed proteins shows almost all of the differentially expressed
proteins were down regulated in infected cells, which is consistent
with the 2D-PAGE result. A full list of the 90 differentially
expressed proteins is given in Supplementary Table S2, and the
cellular distribution and a functional annotation of the 90 highly
significantly differentially expressed proteins is given in Figure 5.
Validation of GeLC-MS/MS results
A total of 6 of the highly differentially expressed proteins,
namely heterogeneous nuclear ribonucleoprotein (hnRNP), nu-
cleolin (NCL), tyrosine-protein kinase JAK2 (JAK2), eukaryotic
elongation factor 2 (EEF2), heat shock protein 70 (Hsp70) and heat
shock protein 90 (Hsp90) together with actin were selected for
confirmatory Western analysis. The candidates were selected as
being representative of signaling (JAK2), stress response (Hsp70
and Hsp90) transcription (NCL and hnRNP) and translation
(EEF2) pathways and results (Figure 6A) were consistent with the
GeLC-MS/MS analysis with all proteins showing significant down
regulation by day 2 p.i.. A further 13 proteins, namely E3
ubiquitin-protein ligase (BRE1B), Cullin-9 (CUL9), chromodo-
main-helicase-DNA binding protein 2 (CHD2), mitochondrial
precursor transcription termination factor (MTERF), regulator of
differentiation 1 isoform (ROD1), phosphatidylinositol-4,5-bispho-
sphate 3-kinase catalytic subunit delta (PIK3CD), mitochondrial
glutaryl-CoA dehydrogenase isoform precursor (GCDH), hy-
droxysteroid dehydrogenase-like protein 2 (HSDL2), 1-phospha-
tidylinositol-4,5-bisphosphate phosphodiesterase eta-2 (PLCH2),
Figure 3. GeLC-MS/MS analysis of the proteome of CHIKV infected CHME-5 cells. CHME-5 cells either mock infected or infected with CHIKV
at MOI 2.5 were collected at day 2 p.i. and proteins extracted and the proteomes determined by GeLC-MS/MS. Each line of the graph represents a
single protein and the intensity of individual proteins is shown. The upper panel of the graph shows differentially expressed proteins significant at
p,0.01. The lower panel shows proteins which are not significant at p,0.01. Samples were analyzed as three independent replicates.
doi:10.1371/journal.pone.0034800.g003
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protein (DRPLA), DENN domain-containing protein 3
(DENNDD3) and Histone 2B (HIST1H2B) together with actin
were selected for analysis by semi-quantitative RT-PCR analysis to
evaluate expression at the level of the RNA message, with the
selected candidates representative of the apoptosis (DENNDD3
and DRPLA), lipid metabolism (ALOX12, PLCH2, HSDL2,
GCDH, PIK3CD), transcription (ROD1, MTERF, HIST1H2B
and CHD2) and ubiquitinylation (BRE1B and CUL9). Results
(Figure 6B) showed that almost all of the selected candidates were
down regulated at the level of gene expression (transcription) with
the exception of Histone H2B which was found up regulated at the
level of transcription.
Discussion
Despite intensive study over the last few years, the detailed
mechanism of the pathology of CHIKV infection remains to be
established. Both old world and new world alphaviruses have been
reported to induce both transcriptional and translational shut off
in infected cells and although the mechanism of this is not
completely known, both the nsP2 protein and the capsid protein
have been implicated in the process of transcriptional shut off
[32,33]. SINV has been shown to induce PKR dependant and
PKR independent translational shut off [40], and while CHIKV
infection induces PKR mediated phosphorylation of eIF2a,i ti s
not essential to the process of global translational shut off,
suggesting that alternate, PKR independent mechanisms exist,
which are possibly specifically targeted at the host cell antiviral
response [34]. In this regard, the cell line used in this study,
CHME-5, was derived from primary human embryonic microglia
by transfection with SV40 large T antigen [36], which has been
shown to rescue translational arrest induced by PKR mediated
phosphorylation of eIF2a [41]. While this could have possibly
confounded the results generated, as noted, PKR mediated
phosphorylation of eIF2a is not believed to be essential to the
process of global translational arrest in CHIKV infection [34].
One possible explanation for the results seen in our proteomic
analysis is simply that after global translational arrest, proteins that
are shown as strongly down regulated are simply proteins with
short half-lives which are removed from the cell by normal protein
turn over by various cellular processes [42]. We therefore looked
at the established half-lives of a number of proteins to determine
whether the strongly down regulated proteins were associated with
short half lives, while the proteins that were not significantly down
regulated had long half lives. Protein half-lives were sourced from
a number of publications [43,44,45]. As shown in Table 1, there
was no discernable association between protein half life and down
regulation significance or lack of it in the proteomic study. This
was exemplified by histone H2B which has a comparatively long
half life of 30 hours [45], but was strongly down regulated in
response to CHIKV infection. Similarly the 40S ribosomal protein
S8 which has a half-life of 3 hours [43] was found at essentially
similar levels in mock and CHIKV infected cells. The time of
sample analysis was 48 hours post infection which would represent
up to 16 half lives for the 40S ribosomal protein S8 which would
result in the effective complete disappearance of this protein.
Therefore the proteomic results do not appear consistent with a
simple global translational shut off.
In cases where eIF2a mediated translational inhibition occurs,
translation can still occur through the utilization of the internal
ribosome entry site (IRES) whereby the ribosome is directly
recruited to a site within the 59-UTR of the mRNA [46]. IRES
directed translation initiation commonly occurs under conditions
where normal, cap-dependant translation is reduced [47]. While
there are few well characterized cellular mRNAs that are capable
of IRES-mediated translation, proteins capable of IRES mediated
translation including p53 [48] and Hsp70 [49] were found in the
significantly down regulated group, suggesting that the result we
observed does not arise from IRES-mediated translation generat-
ing the bulk of the proteins showing no significant change in
expression. Collectively these results suggest that there is a degree
of targeted protein down regulation in addition to any more global
processes ongoing. Furthermore while the Western analysis
confirmed that all proteins we validated were down regulated at
the level of protein expression, at least one gene (Histone 2B) was
found to be transcriptionally up-regulated (as evidenced by semi-
quantitative RT-PCR), but translationally down-regulated (as
evidenced in the GeLC-MS/MS analysis), suggesting that targeted
transcriptional inhibition may also play a role in CHIKV
infection.
Figure 4. Two-way hierarchical clustering analysis of 90 significantly differentially expressed proteins in mock (left) and CHIKV
(right) infected CHME-5 cells. Each column represents a single biological replication and each line represents a single protein. The color scale is
shown by the bar at the top.
doi:10.1371/journal.pone.0034800.g004
Figure 5. Sub-cellular distribution and functional annotation of proteins significantly differentially expressed in response to CHIKV
infection of CHME-5 cells. The sub-cellular (A) and functional (B) categorization of the proteins was performed using the GoCat software.
doi:10.1371/journal.pone.0034800.g005
CHIKV Infection Proteomic Analysis
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e34800Nearly one quarter of all significantly down regulated proteins
were involved with cell signal transduction processes. These
included the G-Protein signaling pathway (GTP-binding protein 1,
guanine nucleotide-binding protein subunit alpha-12, regulator of
G protein signaling 6 alpha1-GGL and regulator of G-protein
signaling 5 isoform 1) and the cytokine receptor JAK/STAT
signaling pathway signaling (JAK2). Many viruses including tick
borne encephalitis [50] and Sindbis virus [51] are known to inhibit
the interferon signaling pathway through different mechanisms to
suppress the innate antiviral immune response. Chikungunya virus
infection has also been shown to suppress the secretion of IFN-b
and translation of interferon stimulated genes (ISGs) in human
fibroblast cells [34], most likely through the action of CHIKV
nsP2 which inhibits interferon stimulated JAK/STAT signaling
through blocking phosphorylation and nuclear translocation [52].
Fros and colleagues showed no decrease in the level of endogenous
STAT protein [52], and STAT was not shown to be significantly
down regulated in this study. Markedly however, JAK2 was shown
to be significantly down regulated in this study suggesting that
JAK2, rather than STAT may be the primary target of nsP2
mediated inhibition of interferon stimulated JAK/STAT signal-
ing.
Another major cellular process altered was lipid metabolism
(7% of significantly down regulated proteins) and viral infections
including dengue virus [53,54,55] West Nile virus [56] and
hepatitis virus [57] are known to induce changes in the lipid
metabolism pathway of the host cell. However, these viruses
Figure 6. Validation of proteins differentially expressed in response to CHIKV infection in CHME-5 cells. (A) CHME-5 cells were either
mock infected or infected with CHIKV at MOI 0.1 before extraction of proteins and analysis by Western blot analysis on 1 and 2 d.p.i. hnRNP:
heterogeneous nuclear ribonucleoprotein; NCL: nucleolin; JAK2: tyrosine-protein kinase JAK2; Hsp70: heat shock protein 70; Hsp90: heat shock
protein 90. (B). CHME-5 cells were either mock infected or infected with CHIKV at MOI 0.1 before extraction of total RNA and analysis by RT-PCR on 1,
2 and 3 d.p.i. BRE1B: E3 ubiquitin-protein ligase; CUL9: Cullin-9; CHD2: chromodomain-helicase-DNA binding protein 2; MTERF: mitochondrial
precursor transcription termination factor; ROD1: regulator of differentiation 1 isoform; PIK3CD: phosphatidylinositol-4,5-bisphosphate 3-kinase
catalytic subunit delta; GCDH: mitochondrial glutaryl-CoA dehydrogenase isoform precursor; HSDL2: hydroxysteroid dehydrogenase-like protein 2;
PLCH2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase eta-2; ALOX12: 12-lipoxygenase; DRPLA: Dentatorubral pallidoluysian atrophy
protein; DENND3: DENN domain-containing protein 3; HIS1H2B: Histone 2B.
doi:10.1371/journal.pone.0034800.g006
Table 1. Values of fold change in response to CHIKV
infection, significance and half life of selected proteins.
Protein Fold change p-value Half-life(hrs)
elongation factor 2 4.91 ,0.001 8.8
Heat shock protein 90 KDa alpha 5.69 ,0.001 4.2
stress-70 protein, mitochondrial
precursor
7.35 0.001 10.6
Nucleolin 6.74 0.008 13.9
Vinculin isoform VCL 5.24 ,0.001 11.7
Histone H2B 7.78 0.009 30
TP53 4.94 0.009 0.2
myosin-9 0.96 NS 6.4
proteasome subunit alpha type-6 1.9 NS 8.5
proteasome subunit alpha type-7 1.2 NS 9
ribosomal protein S2 0.9 NS 19.7
40S ribosomal protein S8 0.7 NS 3.0
60S ribosomal protein L22 proprotein 1.2 NS 11.1
Vimentin 1.0 NS 4.9
doi:10.1371/journal.pone.0034800.t001
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biosynthesis for their own production. While Blanc and colleagues
recently showed that the viral induced innate immune response,
signaling through the interferon receptor, could down-regulated
the sterol biosynthesis pathway in response to infection in
macrophages [58], the evidence presented here suggests that the
innate immunity pathway is down regulated in response to
CHIKV infection. This suggests either a temporal difference in
that innate immunity triggers down regulation of lipid metabolism
prior to the inhibition of this pathway, or down regulation of lipid
biosynthesis occurs as a result of transcriptional or translational
shut off. Another protein in the stress response group, the p53
tumour suppressor protein, has also been shown to be involved in
interferon mediated antiviral defense acting through the JAK/
STAT signaling cascade [59], suggesting that down regulation of
the interferon response pathway is a major target of the CHIKV
transcriptional or translational shut off.
In total, 6 (8%) of the proteins identified as highly down
regulated in response to CHIKV infection were classified in the
stress response group which included both Hsp70 and Hsp90 as
well as p53 as noted above. Heat shock proteins are multifunc-
tional proteins with important roles in folding and assembly of
newly synthesized proteins, the refolding of aggregated or mis-
folded proteins as well as protein trafficking and the regulation of
signal transduction [60]. Hsp70 has been shown to block
replication of Influenza A virus possibly through disrupting the
polymerase-viral RNA complex binding [61] and while a role for
Hsp90 in this inhibition has not been proposed yet, Hsp90 and
Hsp70 are frequently complexed through the action of Hop or
Hsp70/Hsp90 Organizing Protein [62].
A recent proteomic study using CHIKV infected suckling mice
identified 35 differentially down regulated proteins in liver and 15
differentially down regulated proteins in brain, which primarily
belonged to stress, inflammation, apoptosis, urea cycle and energy
metabolism pathways [63]. Both our study and the study of
Dhanwani [63] detect changes in the apoptosis, stress response
and lipid metabolism pathways suggesting the importance of these
pathways, albeit that largely different proteins in these pathways
were identified by the two studies. However, there are several
important technical differences between the Dhanwani study [63]
and our study. In particular the lower number of proteins detected
by Dhanwani and colleagues [63], even when compared to our
2D-PAGE analysis, where we detected 59 differentially regulated
spots may result from the use of tissues of a mixed origin. For
example liver specimens may consist of hepatocytes, liver
sinusoidal cells, kuppfer cells and other cell types as well as
supporting and vascular cells [64]. In this case the sample may
represent a mixed population of cells, of which many may not be
infected, serving to dilute the sensitivity of the analysis. Our
analysis, using a single cell type at a high level of infection,
particularly when coupled to the more sensitive analysis of GeLC-
MS-MS, should provide a more detailed analysis, as seen by the
larger number of proteins identified as being down regulated in
response to infection.
In conclusion, this study shows that CHIKV infection of
CHME-5 cells caused the down regulation of proteins in different
interrelated cellular pathways including cell signaling, lipid
metabolism, protein modification, transcription, translation, and
stress responses. Many of the differentially expressed proteins from
the different pathways however are related to the antiviral innate
immune response of the host cell, suggesting that specific down
regulation of host cell antiviral responses is one of the primary
targets of the apparent global transcriptional shut off.
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